» Articles » PMID: 9321388

Dynamics of Proteasome Distribution in Living Cells

Overview
Journal EMBO J
Date 1997 Oct 8
PMID 9321388
Citations 85
Authors
Affiliations
Soon will be listed here.
Abstract

Proteasomes are proteolytic complexes involved in non-lysosomal degradation which are localized in both the cytoplasm and the nucleus. The dynamics of proteasomes in living cells is unclear, as is their targeting to proteins destined for degradation. To investigate the intracellular distribution and mobility of proteasomes in vivo, we generated a fusion protein of the proteasome subunit LMP2 and the green fluorescent protein (GFP). The LMP2-GFP chimera was quantitatively incorporated into catalytically active proteasomes. The GFP-tagged proteasomes were located within both the cytoplasm and the nucleus. Within these two compartments, proteasomes diffused rapidly, and bleaching experiments demonstrated that proteasomes were transported slowly and unidirectionally from the cytoplasm into the nucleus. During mitosis, when the nuclear envelope has disintegrated, proteasomes diffused rapidly throughout the dividing cell without encountering a selective barrier. Immediately after cell division, the restored nuclear envelope formed a new barrier for the diffusing proteasomes. Thus, proteasomes can be transported unidirectionally over the nuclear membrane, but can also enter the nucleus upon reassembly during cell division. Since proteasomes diffuse rapidly in the cytoplasm and nucleus, they may perform quality control by continuous collision with intracellular proteins, and degrading those proteins that are properly tagged or misfolded.

Citing Articles

Minimizing DNA trapping while maintaining activity inhibition via selective PARP1 degrader.

Chen L, Zou Y, Sun R, Huang M, Zhu X, Tang X Cell Death Dis. 2024; 15(12):898.

PMID: 39695097 PMC: 11655542. DOI: 10.1038/s41419-024-07277-2.


Nuclear envelope budding and its cellular functions.

Keuenhof K, Kohler V, Broeskamp F, Panagaki D, Speese S, Buttner S Nucleus. 2023; 14(1):2178184.

PMID: 36814098 PMC: 9980700. DOI: 10.1080/19491034.2023.2178184.


Nitric Oxide Signaling and Its Association with Ubiquitin-Mediated Proteasomal Degradation in Plants.

Pande A, Mun B, Khan M, Rahim W, Lee D, Lee G Int J Mol Sci. 2022; 23(3).

PMID: 35163578 PMC: 8835921. DOI: 10.3390/ijms23031657.


The Role of Immunoproteasomes in Tumor-Immune Cell Interactions in Melanoma and Colon Cancer.

Leister H, Krause F, Mahdavi R, Steinhoff U, Visekruna A Arch Immunol Ther Exp (Warsz). 2022; 70(1):5.

PMID: 35064840 PMC: 8783903. DOI: 10.1007/s00005-022-00644-x.


A Cell-Based Platform for the Investigation of Immunoproteasome Subunit β5i Expression and Biology of β5i-Containing Proteasomes.

Burov A, Funikov S, Vagapova E, Dalina A, Rezvykh A, Shyrokova E Cells. 2021; 10(11).

PMID: 34831272 PMC: 8616536. DOI: 10.3390/cells10113049.


References
1.
Fabre E, Hurt E . Nuclear transport. Curr Opin Cell Biol. 1994; 6(3):335-42. DOI: 10.1016/0955-0674(94)90023-x. View

2.
Rock K, Gramm C, Rothstein L, Clark K, Stein R, Dick L . Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell. 1994; 78(5):761-71. DOI: 10.1016/s0092-8674(94)90462-6. View

3.
Belich M, Glynne R, Senger G, Sheer D, Trowsdale J . Proteasome components with reciprocal expression to that of the MHC-encoded LMP proteins. Curr Biol. 1994; 4(9):769-76. DOI: 10.1016/s0960-9822(00)00174-3. View

4.
Hendil K, Kristensen P, Uerkvitz W . Human proteasomes analysed with monoclonal antibodies. Biochem J. 1995; 305 ( Pt 1):245-52. PMC: 1136456. DOI: 10.1042/bj3050245. View

5.
GOLDBERG A . Functions of the proteasome: the lysis at the end of the tunnel. Science. 1995; 268(5210):522-3. DOI: 10.1126/science.7725095. View